MigraineMind research summary
<i>DNAJC12</i> p.Asp44Gly associated with mild hyperphenylalaninemia and migraine-like headaches: Structural and deep learning analyses.
Mol Genet Metab Rep | 2026
Observational studySummary
A recent study explored a genetic variant in the DNAJC12 gene. This variant is linked to mild hyperphenylalaninemia and migraine-like headaches. Researchers examined a 19-year-old man with these symptoms. He also showed white matter changes similar to phenylketonuria. The study identified four other relevant genetic variants. They used deep learning and traditional methods to analyze the data. Various algorithms helped assess the potential impact of these variants. Techniques like AlphaFold2 and PCA were employed to understand the protein's structure and function. The findings suggest that the genetic variant could affect neurotransmitter levels. This might explain the migraine-like headaches experienced by the patient. Overall, the research highlights the complex relationship between genetics and migraine symptoms. Further studies could help clarify these connections and improve patient outcomes. Clinical relevance: This research indicates that genetic factors may contribute to migraine-like headaches, potentially guiding personalized treatment approaches for affected individuals.
Key Learning Points
- A specific genetic variant in the DNAJC12 gene is associated with mild hyperphenylalaninemia and migraine-like headaches in affected individuals.
- The study found that the identified genetic variant may influence neurotransmitter levels, which could contribute to migraine symptoms.
- White matter changes observed in the patient resembled those seen in phenylketonuria, suggesting a need for further investigation into related conditions.
- Advanced techniques like deep learning and AlphaFold2 were used to analyze genetic data and protein structure, enhancing our understanding of these variants.
- Understanding the genetic factors behind migraines could lead to more personalized and effective treatment options for patients experiencing these symptoms.
Original research
Read the original publication and review its full methods and findings on PubMed.
MigraineMind is an educational resource designed to complement—not replace—the original scientific literature or clinical judgement. This page is an AI-generated summary of the available paper information and may contain errors. Please consult the original publication.